//
Work at this foundation?
Claim this profile to manage it and see interest from grant seekers.
Archer Foundation is a private corporation based in LAS VEGAS, NV. The foundation received its IRS ruling in 2012. The principal officer is Matthew D Van Steenwyk. It holds total assets of $1.1M. Annual income is reported at $64K. Total assets have decreased from $2.5M in 2012 to $1.1M in 2024. The foundation is governed by 5 officers and trustees. In 2020, the organization made contributions to yale university to advance understanding of neurodegeneration focused on developing novel pet tracers to provide a noninvasive,reliable, and sensitive method for quantifying synaptic loss in the early detection of alzheimer's disease. According to its most recent filing, the foundation only makes contributions to preselected charitable organizations. Tax records are available from 2015 to 2024. The foundation primarily funds organizations in California, Missouri and Connecticut. According to available records, Archer Foundation has made 7 grants totaling $500K, with a median grant of $75K. Annual giving has decreased from $300K in 2020 to $200K in 2021. Individual grants have ranged from $25K to $100K, with an average award of $71K. The foundation has supported 4 unique organizations. Grants have been distributed to organizations in Missouri and Connecticut and California. Contributions to this foundation are tax-deductible.
Smallest Grant
$25K
Median Grant
$75K
Average Grant
$67K
Largest Grant
$100K
Based on 3 grants from the most recent 990-PF filing.
In 2020, the organization made contributions to yale university to advance understanding of neurodegeneration focused on developing novel pet tracers to provide a noninvasive,reliable, and sensitive method for quantifying synaptic loss in the early detection of alzheimer's disease.
Expenses: $100K
In 2020, the organization made contributions to washington university to advance understanding of neurosciences with a particular focus on role of fluid-based biomarkers to aid in the study of alzheimer disease.
Expenses: $100K
In 2020, the organzation made contributions to stanford university research management group to support the research of miro, an early molecular measurment for parkinson's disease.
Expenses: $75K
In 2020, the organzation made contributions to regents of the university of california to support the research of vascular-induced astrocytic signaling in neurodegenerative disease.
Expenses: $25K
In 2020, the organization made contributions to yale university to advance understanding of neurodegeneration focused on developing novel pet tracers to provide a noninvasive,reliable, and sensitive method for quantifying synaptic loss in the early detection of alzheimer's disease. Based on available records, the foundation has funded 7 grants. Its grantmaking reaches organizations primarily in MO, CT, CA.
Archer Foundation has distributed a total of $500K across 7 grants. The median grant size is $75K, with an average of $71K. Individual grants have ranged from $25K to $100K.
Archer Foundation typically selects its grantees rather than accepting unsolicited proposals.
Archer Foundation is headquartered in LAS VEGAS, NV. While based in NV, the foundation distributes grants to organizations across 3 states.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Gretchen C Van Steenwyk | TRUSTEE | $0 | $0 | N/A |
| Betty L Van Steenwyk | TRUSTEE, PRESIDENT | $0 | $0 | N/A |
| Matthew D Van Steenwyk | TRUSTEE, TREASURER | $0 | $0 | N/A |
| Elizabeth Busby | TRUSTEE, SECRETARY | $0 | $0 | N/A |
| Matthew T Van Steenwyk | TRUSTEE | $0 | $0 | N/A |
Total Giving
N/A
Total Assets
$1.1M
Fair Market Value
N/A
Net Worth
$1.1M
Grants Paid
N/A
Contributions
N/A
Net Investment Income
N/A
Distribution Amount
N/A
Total Grants
7
Total Giving
$500K
Average Grant
$71K
Median Grant
$75K
Unique Recipients
4
Most Common Grant
$100K
of 2021 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Washington UniversityTO ADVANCE UNDERSTANDING OF NEUROSCIENCES WITH A PARTICULAR FOCUS ON ROLE OF FLUID-BASED BIOMARKERS TO AID IN THE STUDY OF ALZHEIMER DISEASE. | St Louis, MO | $100K | 2021 |
| Yale UniversityTO ADVANCE UNDERSTANDING OF NEURODEGENERATION FOCUSED ON DEVELOPING NOVEL PET TRACERS TO PROVIDE A NONINVASIVE, RELIABLE, AND SENSITIVE METHOD FOR QUANTIFYING SYNAPTIC LOSS IN THE EARLY DETECTION OF ALZHEIMER'S DISEASE. | New Haven, CT | $75K | 2021 |
| Stanford University Research Management GroupTO SUPPORT THE RESEARCH OF MIRO, AN EARLY MOLECULAR MEASURMENT FOR PARKINSON'S DISEASE. | Palo Alto, CA | $25K | 2021 |
| Regents Of The University Of CaliforniaTO SUPPORT THE RESEARCH OF VASCULAR-INDUCED ASTROCYTIC SIGNALING IN NEURODEGENERATIVE DISEASE. | Berkeley, CA | $25K | 2020 |